DDDP, GSK TPO licensing deal

3-Dimensional (DDDP) exclusively licensed from GlaxoSmithKline (GSK; LSE:GSK) worldwide development, marketing and distribution rights to preclinical compound GW 395058 to prevent and treat thrombocyt...